Leadership Overview
Hemofarm has 4 executives leading key functions including strategy, finance, marketing, and supply chain operations.
Driven by a commitment to health, Hemofarm leads the Serbian pharmaceutical market, exporting over 79.1% of the nation's medicinal products and producing over 4 billion tablets and capsules annually.
Driven by a commitment to health, Hemofarm leads the Serbian pharmaceutical market, exporting over 79.1% of the nation's medicinal products and producing over 4 billion tablets and capsules annually.
Leadership Roles at Hemofarm
Dr. Seeliger - President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm
Dr. Seeliger, the President & Chief Executive Officer, Stada Balkan Cluster & Hemofarm at Hemofarm, directs the overarching strategy and operational execution across the Balkan region. This leadership role involves driving market share growth, ensuring robust financial performance, and upholding Hemofarm's commitment to health. Overseeing critical functions, Dr. Seeliger ensures alignment with Stada's global objectives while maintaining Hemofarm's position as the leading pharmaceutical company in Serbia and the region. The executive's focus extends to optimizing production processes, which yield over 4 billion tablets and capsules annually, and reinforcing the company's status as the leading Serbian exporter of medicinal products. By championing innovation and operational excellence, Dr. Seeliger solidifies Hemofarm's market leadership and its dedication to advancing healthcare solutions. This executive's strategic vision guides the company's expansion and its significant contribution to the regional pharmaceutical landscape.
Vidosava Aleksic - Chief Financial Officer, Pomocnik
Vidosava Aleksic, the Chief Financial Officer, Pomocnik at Hemofarm, manages all financial operations and strategic fiscal planning for the company. This role is critical in maintaining Hemofarm's leading position in the Serbian pharmaceutical market, which holds a 17.3% share in financial terms. Vidosava Aleksic oversees budgeting, financial reporting, and investment strategies, ensuring the company's sustained profitability and growth. The executive's responsibilities include optimizing financial resources to support the production of over 4 billion tablets and capsules annually and reinforcing Hemofarm's dominance as the leading Serbian exporter of medicinal products. By ensuring fiscal discipline and strategic financial management, Vidosava Aleksic directly contributes to the company's ability to invest in research, development, and market expansion. This leadership ensures the financial health necessary for Hemofarm to continue its commitment to care for health across the region.
Danijela Viciknez - Regional Chief Marketing Officer, Head Supply Network
Danijela Viciknez, the Regional Chief Marketing Officer, Head Supply Network at Hemofarm, drives integrated marketing strategies and oversees the entire supply chain network. This dual focus ensures that Hemofarm's commitment to health is effectively communicated and that its extensive production of over 4 billion tablets and capsules annually reaches markets efficiently. Danijela Viciknez leads initiatives to expand Hemofarm's significant export share, which accounts for 79.1% of Serbian pharmaceutical products, reinforcing its status as the leading regional exporter. The executive's marketing expertise ensures strong brand presence and market penetration, while the supply network leadership guarantees operational efficiency and product availability across diverse geographies. By synchronizing marketing efforts with supply chain logistics, Danijela Viciknez optimizes resource allocation and enhances customer satisfaction, directly supporting Hemofarm's market leadership in Serbia and beyond.
Tijana Marković - Chief Marketing Officer, Fmd & Specialist
Tijana Marković, the Chief Marketing Officer, Fmd & Specialist at Hemofarm, spearheads specialized marketing initiatives and product development strategies. This role is pivotal in maintaining Hemofarm's leading edge in the pharmaceutical sector, focusing on innovative product launches and targeted market campaigns. Tijana Marković ensures that the company's commitment to health resonates with specific patient needs and healthcare professional recommendations. The executive's expertise drives the strategic positioning of Hemofarm's extensive product portfolio, including the over 4 billion tablets and capsules produced annually. By focusing on specialized marketing and product expertise, Tijana Marković enhances Hemofarm's reputation and market share, contributing significantly to its role as the leading pharmaceutical company in Serbia and the region. This leadership ensures that Hemofarm remains at the forefront of pharmaceutical advancements and patient care.
Explore Leadership Teams in Manufacturing
Baxter International is a global healthcare company that develops and manufactures medical devices, pharmaceuticals, and hospital care products. Its offerings include infusion systems, injectable therapies, surgical technologies, and patient monitoring solutions used by hospitals, clinics, and healthcare providers worldwide.
Company Leadership
AZ
VS
Emcure Pharmaceuticals Limited is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products and healthcare solutions. Headquartered in Pune, India, the organization operates as an international pharmaceutical enterprise with a strong presence in both domestic and global healthcare markets. The company focuses on delivering innovative and affordable medicines that address a wide spectrum of medical conditions and therapeutic needs across the healthcare sector. The organization is driven by a research-focused strategy that emphasizes innovation, scientific advancement, and the development of effective therapeutic solutions. Through its research and development capabilities, Emcure Pharmaceuticals works to discover and formulate medicines that address unmet medical needs and improve patient outcomes. The company’s research initiatives focus on areas such as complex generics, biosimilars, biologics, and specialized pharmaceutical formulations. These research efforts allow the organization to continuously introduce improved therapies and drug delivery systems designed to enhance treatment effectiveness and patient safety.
Company Leadership SM
RP
Alcami is a contract development and manufacturing organization headquartered in North Carolina with over 40 years of experience advancing products through every stage of the development lifecycle. Leveraging 675,000 ft across the United States, Alcami serves pharmaceutical and biotech companies of all sizes providing customizable and innovative solutions for analytical development, clinical to commercial sterile and oral solid manufacturing, packaging, microbiology, cGMP biostorage, environmental monitoring, and pharmaceutical support services.
Company Leadership RS
KS
Alexion is a global biopharmaceutical company focused on the discovery, development, and commercialization of medicines for severe and life-threatening rare disorders. The company was established in 1992 and is headquartered in Boston, Massachusetts.
Company Leadership SG
PC
MO
YS
Frequently Asked Questions Regarding Hemofarm Top Executives and Leadership Team
